- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
John Neal Provides an Overview of Health Plan Trends
John Neal, vice president, EMD Serono Managed Markets, says that this year's EMD Serono Specialty Digest identifies several emerging trends in health plans.
John Neal, vice president, EMD Serono Managed Markets, says that this year’s EMD Serono Specialty Digest identifies several emerging trends in health plans. In particular, the study finds new information about trends in benefit design and utilization management. He notes that EMD Serono has been publishing its Specialty Digest for nearly a decade. The publication serves as a valuable resource to a variety of healthcare stakeholders.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
